SONACARE MEDICAL

Salvage focal ablative therapy for radio-recurrent prostate cancer is safe and provides good short to medium-term oncological control

Retrieved on: 
Tuesday, June 2, 2020
Medicine, Medical specialties, Clinical medicine, Prostate cancer, Surgical oncology, Medical physics, RTT, Prostatectomy, Prostate, Radiation therapy, Management of prostate cancer, Cryoablation

An alternative is radical salvage surgery (called salvage prostatectomy) which removes what is left of the prostate after radiation.

Key Points: 
  • An alternative is radical salvage surgery (called salvage prostatectomy) which removes what is left of the prostate after radiation.
  • Focal therapy uses different forms of energy, noninvasively or minimally invasively, to target and treat selectively only those regions of the prostate where cancer has recurred.
  • Prost8 UK charity: 1182590 is a UK charity concentrating on the major advances in minimally invasive prostate cancer treatment enabled through focal therapy.
  • Men who are concerned about prostate cancer should in the first instance discuss this with their family doctor (GP).

SonaCare Medical's CSO, Naren Sanghvi, Recognized by Prestigious Focused Ultrasound Foundation with 2018 Visionary Award

Retrieved on: 
Thursday, October 25, 2018
Medical ultrasonography, High-intensity focused ultrasound, Medicine, Ultrasound, Insightec, Health, Medical equipment, Foundation for Focused Ultrasound Research, Therapeutic ultrasound

CHARLOTTE, N.C., Oct. 25, 2018 /PRNewswire/ -- SonaCare Medical, the leading developer and manufacturer of high intensity focused ultrasound (HIFU) technologies, congratulatesNaren Sanghvion his receipt ofthe Focused Ultrasound Foundation's 2018 Visionary Award, which recognizes his crucial role in advancing the field of focused ultrasound.

Key Points: 
  • CHARLOTTE, N.C., Oct. 25, 2018 /PRNewswire/ -- SonaCare Medical, the leading developer and manufacturer of high intensity focused ultrasound (HIFU) technologies, congratulatesNaren Sanghvion his receipt ofthe Focused Ultrasound Foundation's 2018 Visionary Award, which recognizes his crucial role in advancing the field of focused ultrasound.
  • The mission of the Focused Ultrasound Foundation is to accelerate the development and adoption of focused ultrasound technology as a standard of care.
  • Naren's contributions have made SonaCare Medical both an industry and technology leader in the field of focused ultrasound ablation.
  • "We are proud to have Naren Sanghvi recognized by the Focused Ultrasound Foundation," comments SonaCare Medical CEO, Dr. Mark Carol.

5-Year Outcomes Following A HIFU Focal Therapy Study Demonstrate Impressive Disease Control And Low Side Effect Profile For Prostate Cancer Patients In The U.K.

Retrieved on: 
Thursday, July 5, 2018
Medicine, Anatomy, RTT, Prostate cancer, Cancer, Medical physics, Histopathology, High-intensity focused ultrasound, Prostate, Management of prostate cancer, Prostate cancer screening

"Focal HIFU is a major shift in treating men with early prostate cancer.

Key Points: 
  • "Focal HIFU is a major shift in treating men with early prostate cancer.
  • This study shows it is possible to achieve whole-gland equivalent cancer control rates without the concomitant side effect profile of whole gland treatments.
  • Now, otherwise healthy men with prostate cancer can leave the hospital post focal HIFU treatment with their cancer under control yet still healthy.
  • A Multicentre Study of 5-year Outcomes Following Focal Therapy in Treating Clinically Signicant Nonmetastatic Prostate Cancer.